James D Berry

James D Berry

UNVERIFIED PROFILE

Are you James D Berry?   Register this Author

Register author
James D Berry

James D Berry

Publications by authors named "James D Berry"

Are you James D Berry?   Register this Author

49Publications

1304Reads

40Profile Views

Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis.

Muscle Nerve 2019 08 27;60(2):147-154. Epub 2019 Jun 27.

Harvard Medical School, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, 165 Cambridge St, Suite 600, Boston, Massachusetts, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.26606DOI Listing
August 2019

Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one center.

Muscle Nerve 2019 08 20;60(2):137-140. Epub 2019 Jun 20.

Healey Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.26607DOI Listing
August 2019

Learning from history: Lord Brain and Hashimoto's encephalopathy.

Pract Neurol 2019 Aug 26;19(4):316-320. Epub 2019 Jun 26.

Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/practneurol-2018-002107DOI Listing
August 2019

Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis.

Neurology 2019 Apr 14;92(18):e2081-e2088. Epub 2018 Nov 14.

From the Departments of Nutrition (K.B., É.J.O., Z.Z., A.A.) and Epidemiology (J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (É.J.O.), College of Medicine, University College Cork, Ireland; Department of Neurology (J.D.B., M.A.S.), Massachusetts General Hospital (S.P.), Boston; Metabolomics Platform (C.B.C., S.J.), Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge; Department of Oncology (I.K.), Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Epidemiology Research Program (M.L.M.), American Cancer Society, Atlanta, GA; Department of Physical Medicine and Rehabilitation (S.P.), Spaulding Rehabilitation Hospital, Charlestown; Harvard Medical School (S.P., M.A.S.), Boston, MA; Department of Epidemiology (E.O.T.), Graduate School of Public Health, University of Pittsburgh, PA; Department of Epidemiology (R.B.W.), College of Public Health, University of Iowa, Iowa City; and Department of Medicine (J.E.M.) and Channing Division of Network Medicine (A.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006669DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512885PMC
April 2019

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.

Neurology 2019 Apr 8;92(14):e1610-e1623. Epub 2019 Mar 8.

From the Department of Neurology (L.H.v.d.B.), Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands; Department of Neurology (E.S.), Mayo Clinic, Rochester, MN; Department of Neurology (G.G.), University of Kansas Medical Center, Kansas City; Department of Medicine (E.A.M.), Massachusetts General Hospital, Biostatistics Center, Harvard Medical School, Boston; Department of Neurology (J.A., H.M.), Columbia University, Eleanor and Lou Gehrig ALS Center, New York, NY; Department of Neurology (R.H.B.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Neurology (M.B.), University of Miami, FL; Neurological Clinical Research Institute (J.D.B.), Massachusetts General Hospital, Boston; Rita Levi Montalcini Department of Neuroscience (A.C.), University of Torino, Italy; Centre Constitutif SLA (P.C.), Université de Tours, France; Department of Neurology (A.G.), Clinical Research Unit, Montreal Neurological Institute, Neurosurgery, McGill University, Montreal, Canada; National Institute of Neurological Disorders and Stroke (A.K.G.), National Institutes of Health, Bethesda, MD; ALS Center (C.L.-H.), University of California San Francisco; Department of Neuroscience (C.J.M.), Sheffield Institute for Translational Neuroscience, University of Sheffield, UK; Department of Neurology (E.P.P.), Section of ALS & Related Disorders, Cleveland Clinic, OH; Department of Neurology (J.R.), The Center for Restorative Neurology, Loma Linda University School of Medicine, CA; Department of Neurology and Laboratory of Neuroscience (V.S.), Istituto Auxologico Italiano, IRCCS, Milan; Department of Pathophysiology and Transplantation (V.S.), "Dino Ferrari" Centre, Università degli Studi di Milano, Milan, Italy; Nuffield Department of Clinical Neurosciences (M.R.T.), University of Oxford, UK; Neuromuscular Diseases Unit/ALS Clinic (M.W.), Kantonsspital St. Gallen, Switzerland; Carolinas Neuromuscular/ALS-MDA Care Center (B.R.B.), Charlotte; Department of Neurology (B.R.B.), Carolinas Medical Center, University of North Carolina School of Medicine, Charlotte; Forbes Norris ALS Treatment and Research Center (R.G.M.), California Pacific Medical Center San Francisco; and Department of Neurosciences (R.G.M.), Stanford University, CA.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000007242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448453PMC
April 2019

Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis.

Neurology 2019 Apr 29;92(18):e2089-e2100. Epub 2019 Mar 29.

From the Departments of Nutrition (K.B., Z.Z., É.J.O., D.D.W., A.A.) and Epidemiology (L.L., J.E.M., A.A.), Harvard T.H. Chan School of Public Health, Boston, MA; School of Public Health (É.J.O.), College of Medicine, University College Cork, Ireland; Department of Neurology (J.D.B., M.A.S.), Massachusetts General Hospital, Boston; Metabolomics Platform (C.B.C., A.D., S.J., K.A.P.), Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA; Department of Oncology (I.K.), Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Channing Division of Network Medicine (R.S.K., A.A.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Epidemiology Program (L.N.K., L.L.M.), University of Hawaii Cancer Center, Honolulu; Behavioral and Epidemiology Research Group (M.L.M.), American Cancer Society, Atlanta, GA; Department of Physical Medicine and Rehabilitation (S.P.), Spaulding Rehabilitation Hospital and Massachusetts General Hospital; Harvard Medical School (S.P., M.A.S.), Boston, MA; Family Medicine and Public Health (A.H.S.), School of Medicine, University of California San Diego; Epidemiology and Environmental Health, Public Health and Health Professions (J.W.-W.), University at Buffalo, NY; Behavioral and Epidemiology Research Group (Y.W.), American Cancer Society, Atlanta, GA; and Department of Medicine (J.E.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512888PMC
April 2019

Heterogeneity, urgency, generalizability, and enrollment: The HUGE balance in ALS trials.

Neurology 2019 Jan 9. Epub 2019 Jan 9.

From the Department of Neurology (C.K.), Oregon Health & Science University, Portland; and Department of Neurology (J.D.B.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006837DOI Listing
January 2019

Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.

Muscle Nerve 2018 Aug 25;58(2):261-269. Epub 2018 Mar 25.

Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.26106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103911PMC
August 2018

Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study.

Neurol Neuroimmunol Neuroinflamm 2018 Jul 18;5(4):e465. Epub 2018 May 18.

Houston Methodist Neurological Institute (J.R.T., D.R.B., W.Z., M.P., E.P.S., S.H.A.), Houston Methodist Hospital Research Institute, Stanley H. Appel Department of Neurology, Houston, TX; and Neurological Clinical Research Institute (J.D.B., M.E.C.), Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000465DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961523PMC
July 2018

Improved stratification of ALS clinical trials using predicted survival.

Ann Clin Transl Neurol 2018 Apr 9;5(4):474-485. Epub 2018 Mar 9.

Voyager Therapeutics, Inc. Cambridge Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899911PMC
April 2018

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Authors:
Aude Nicolas Kevin P Kenna Alan E Renton Nicola Ticozzi Faraz Faghri Ruth Chia Janice A Dominov Brendan J Kenna Mike A Nalls Pamela Keagle Alberto M Rivera Wouter van Rheenen Natalie A Murphy Joke J F A van Vugt Joshua T Geiger Rick A Van der Spek Hannah A Pliner Shankaracharya Bradley N Smith Giuseppe Marangi Simon D Topp Yevgeniya Abramzon Athina Soragia Gkazi John D Eicher Aoife Kenna Gabriele Mora Andrea Calvo Letizia Mazzini Nilo Riva Jessica Mandrioli Claudia Caponnetto Stefania Battistini Paolo Volanti Vincenzo La Bella Francesca L Conforti Giuseppe Borghero Sonia Messina Isabella L Simone Francesca Trojsi Fabrizio Salvi Francesco O Logullo Sandra D'Alfonso Lucia Corrado Margherita Capasso Luigi Ferrucci Cristiane de Araujo Martins Moreno Sitharthan Kamalakaran David B Goldstein Aaron D Gitler Tim Harris Richard M Myers Hemali Phatnani Rajeeva Lochan Musunuri Uday Shankar Evani Avinash Abhyankar Michael C Zody Julia Kaye Steven Finkbeiner Stacia K Wyman Alex LeNail Leandro Lima Ernest Fraenkel Clive N Svendsen Leslie M Thompson Jennifer E Van Eyk James D Berry Timothy M Miller Stephen J Kolb Merit Cudkowicz Emily Baxi Michael Benatar J Paul Taylor Evadnie Rampersaud Gang Wu Joanne Wuu Giuseppe Lauria Federico Verde Isabella Fogh Cinzia Tiloca Giacomo P Comi Gianni Sorarù Cristina Cereda Philippe Corcia Hannu Laaksovirta Liisa Myllykangas Lilja Jansson Miko Valori John Ealing Hisham Hamdalla Sara Rollinson Stuart Pickering-Brown Richard W Orrell Katie C Sidle Andrea Malaspina John Hardy Andrew B Singleton Janel O Johnson Sampath Arepalli Peter C Sapp Diane McKenna-Yasek Meraida Polak Seneshaw Asress Safa Al-Sarraj Andrew King Claire Troakes Caroline Vance Jacqueline de Belleroche Frank Baas Anneloor L M A Ten Asbroek José Luis Muñoz-Blanco Dena G Hernandez Jinhui Ding J Raphael Gibbs Sonja W Scholz Mary Kay Floeter Roy H Campbell Francesco Landi Robert Bowser Stefan M Pulst John M Ravits Daniel J L MacGowan Janine Kirby Erik P Pioro Roger Pamphlett James Broach Glenn Gerhard Travis L Dunckley Christopher B Brady Neil W Kowall Juan C Troncoso Isabelle Le Ber Kevin Mouzat Serge Lumbroso Terry D Heiman-Patterson Freya Kamel Ludo Van Den Bosch Robert H Baloh Tim M Strom Thomas Meitinger Aleksey Shatunov Kristel R Van Eijk Mamede de Carvalho Maarten Kooyman Bas Middelkoop Matthieu Moisse Russell L McLaughlin Michael A Van Es Markus Weber Kevin B Boylan Marka Van Blitterswijk Rosa Rademakers Karen E Morrison A Nazli Basak Jesús S Mora Vivian E Drory Pamela J Shaw Martin R Turner Kevin Talbot Orla Hardiman Kelly L Williams Jennifer A Fifita Garth A Nicholson Ian P Blair Guy A Rouleau Jesús Esteban-Pérez Alberto García-Redondo Ammar Al-Chalabi Ekaterina Rogaeva Lorne Zinman Lyle W Ostrow Nicholas J Maragakis Jeffrey D Rothstein Zachary Simmons Johnathan Cooper-Knock Alexis Brice Stephen A Goutman Eva L Feldman Summer B Gibson Franco Taroni Antonia Ratti Cinzia Gellera Philip Van Damme Wim Robberecht Pietro Fratta Mario Sabatelli Christian Lunetta Albert C Ludolph Peter M Andersen Jochen H Weishaupt William Camu John Q Trojanowski Vivianna M Van Deerlin Robert H Brown Leonard H van den Berg Jan H Veldink Matthew B Harms Jonathan D Glass David J Stone Pentti Tienari Vincenzo Silani Adriano Chiò Christopher E Shaw Bryan J Traynor John E Landers

Neuron 2018 03;97(6):1268-1283.e6

Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuron.2018.02.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867896PMC
March 2018

Experience with telemedicine in a multi-disciplinary ALS clinic.

Amyotroph Lateral Scler Frontotemporal Degener 2018 02 18;19(1-2):143-148. Epub 2017 Dec 18.

a Harvard Medical School , Spaulding Rehabilitation Hospital , Charlestown , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21678421.2017.1392577DOI Listing
February 2018

Developing multidisciplinary clinics for neuromuscular care and research.

Muscle Nerve 2017 Nov 29;56(5):848-858. Epub 2017 Aug 29.

Harvard Medical School, Department of Neurology, Massachusetts General Hospital (MGH), Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.25725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656914PMC
November 2017

The diagnostic utility of patient-report and speech-language pathologists' ratings for detecting the early onset of bulbar symptoms due to ALS.

Amyotroph Lateral Scler Frontotemporal Degener 2017 08 29;18(5-6):358-366. Epub 2017 Mar 29.

a Department of Communication Sciences and Disorders , MGH Institute of Health Professions , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21678421.2017.1303515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530595PMC
August 2017

Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems.

PLoS One 2016 5;11(5):e0154971. Epub 2016 May 5.

Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154971PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858181PMC
July 2017

Poly(GP) proteins are a useful pharmacodynamic marker for -associated amyotrophic lateral sclerosis.

Sci Transl Med 2017 03;9(383)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aai7866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576451PMC
March 2017

Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis.

Muscle Nerve 2015 Oct 3;52(4):584-91. Epub 2015 Jun 3.

ALS/MND Clinic, Sunnybrook Health Sciences Centre, Department of Neurology, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mus.24565
Publisher Site
http://dx.doi.org/10.1002/mus.24565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499330PMC
October 2015

Amyotrophic Lateral Sclerosis: Review.

Semin Neurol 2015 Aug 6;35(4):469-76. Epub 2015 Oct 6.

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0035-1558984DOI Listing
August 2015

Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?

Neurotherapeutics 2015 Apr;12(2):376-83

Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, 165 Cambridge Street, Suite 600, Boston, MA, 02114, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-015-0341-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404442PMC
April 2015

Neuroprotective agents target molecular mechanisms of disease in ALS.

Drug Discov Today 2015 Jan 6;20(1):65-75. Epub 2014 Sep 6.

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2014.08.016DOI Listing
January 2015

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone.

Toxicol Rep 2015;2:1396-1403

Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Boston, MA, Massachusetts General Hospital, 165 Cambridge Street, Suite 600, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.toxrep.2015.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685718PMC
January 2015

FUS is sequestered in nuclear aggregates in ALS patient fibroblasts.

Mol Biol Cell 2014 Sep 9;25(17):2571-8. Epub 2014 Jul 9.

Howard Hughes Medical Institute, Department of Chemistry and Biochemistry and BioFrontiers Institute, University of Colorado, Boulder, CO 80309

View Article

Download full-text PDF

Source
http://www.molbiolcell.org/doi/10.1091/mbc.e14-05-1007
Publisher Site
http://dx.doi.org/10.1091/mbc.E14-05-1007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148247PMC
September 2014

Reevaluating the risk of DVT in people with ALS: weak in the knees and DVTs.

Neurology 2014 May 11;82(19):1668-9. Epub 2014 Apr 11.

From the Neurological Clinical Research Institute (J.D.B.), Massachusetts General Hospital, Boston; and the Hotchkiss Brain Institute (L.K.), University of Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000420DOI Listing
May 2014

Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons.

Cell Rep 2014 Apr 3;7(1):1-11. Epub 2014 Apr 3.

FM Kirby Neurobiology Center, Boston Children's Hospital and Harvard Stem Cell Institute, Boston, MA 02115, USA; Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.03.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023477PMC
April 2014

Predicting success: optimizing phase II ALS trials for the transition to phase III.

Amyotroph Lateral Scler Frontotemporal Degener 2014 Mar;15(1-2):1-8

Massachusetts General Hospital, Neurological Clinical Research Center , Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/21678421.2013.838969DOI Listing
March 2014

Outcome measures in amyotrophic lateral sclerosis clinical trials.

Clin Investig (Lond) 2014 ;4(7):605-618

Harvard Medical School, Department of Neurology, Neurological Clinical Research Institute (NCRI), Massachusetts Genera Hospital, MA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305182PMC
January 2014

Bulbar and speech motor assessment in ALS: challenges and future directions.

Amyotroph Lateral Scler Frontotemporal Degener 2013 Dec 30;14(7-8):494-500. Epub 2013 Jul 30.

The Department of Communication Sciences and Disorders, MGH Institute of Health Professions , Massachusetts , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/21678421.2013.817585DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833808PMC
December 2013

Feedback interaction of research, advocacy, and clinical care applied to ALS research in South America.

Neurology 2013 Nov;81(22):1959-61

From the University of Massachusetts Medical School (M.E.B., J.S.), Worcester; San Francisco University of Quito (A.C., D.C., C.F., R.L.), Ecuador; Wellesley College (E.D.), MA; and Massachusetts General Hospital (N.A., J.D.B.), Harvard Medical School, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000436610.28210.a5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843379PMC
November 2013

The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.

Amyotroph Lateral Scler Frontotemporal Degener 2013 Apr 17;14(3):162-8. Epub 2013 Jan 17.

Massachusetts General Hospital, Neurological Clinical Research Institute, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/21678421.2012.762930DOI Listing
April 2013

Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: subgroup analysis of demographic and clinical characteristics.

Amyotroph Lateral Scler Frontotemporal Degener 2013 Jan 17;14(1):44-51. Epub 2012 Sep 17.

Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/17482968.2012.723723DOI Listing
January 2013

Biochemical alterations associated with ALS.

Amyotroph Lateral Scler 2012 Jan 25;13(1):110-8. Epub 2011 Nov 25.

Metabolon Inc., North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/17482968.2011.619197DOI Listing
January 2012

New considerations in the design of clinical trials for amyotrophic lateral sclerosis.

Clin Investig (Lond) 2011 Oct;1(10):1375-1389

Massachusetts General Hospital, Department of Neurology, Neurology Clinical Trials Unit, 149 Thirteenth Street, Suite 2274, Charlestown, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/cli.11.127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335743PMC
October 2011

A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster.

Neurology 2005 Aug;65(3):444-7

UCSF Pain Clinical Research Center, Department of Neurology, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000168259.94991.8aDOI Listing
August 2005

Complex regional pain syndrome-like symptoms during herpes zoster.

Pain 2004 Jul;110(1-2):e1-12

UCSF Pain Clinical Research Center, University of California, San Francisco 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pain.2003.12.038DOI Listing
July 2004